title: Dasatinib medication causing profound immunosuppression in a patient after haploidentical SCT: functional assays from whole blood as diagnostic clues.
authors.forename: M
authors.initials: M
authors.lastname: Wölfl
authors.forename: F
authors.initials: F
authors.lastname: Langhammer
authors.forename: V
authors.initials: V
authors.lastname: Wiegering
authors.forename: M
authors.initials: M
authors.lastname: Eyrich
authors.forename: P G
authors.initials: PG
authors.lastname: Schlegel
mesh_terms: D064591:Allografts; D018414:CD8-Positive T-Lymphocytes; D002648:Child; D004266:DNA Virus Infections / Q000097:blood / Q000139:chemically induced; D000069439:Dasatinib; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000097:blood / Q000139:chemically induced; D018655:Lymphocyte Count; D008218:Lymphocytosis / Q000097:blood / Q000139:chemically induced; D008297:Male; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000097:blood / Q000628:therapy; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D011743:Pyrimidines / Q000008:administration & dosage / Q000009:adverse effects*; D033581:Stem Cell Transplantation; D013844:Thiazoles / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D013844:Thiazoles; D000069439:Dasatinib